Featured
ASX healthcare stocks fell sharply this week, but TTX could benefit from moves to ease restrictions on peptides in US.
Stockhead’s end-of-week wrap covering small-cap ASX movers, news of note and expert recommendations – this week, from Brad Seward.
Dr Farah explains how its InVue and InForm technologies could improve surgical outcomes and the path to FDA submissions.
Tim Boreham speaks to CEO of icetana, Kevin Brown about the growing role of AI in physical security.
